Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells

被引:62
作者
Li, Jiajin [1 ,2 ]
Yan, Hui [1 ,2 ]
Zhao, Li [1 ,2 ]
Jia, Wenzhi [1 ,2 ]
Yang, Hao [3 ,4 ]
Liu, Liu [1 ,2 ]
Zhou, Xiang [1 ,2 ]
Miao, Ping [1 ,2 ]
Sun, Xiaoguang [1 ,2 ]
Song, Shaoli [1 ,2 ]
Zhao, Xiaoping [1 ,2 ]
Liu, Jianjun [1 ,2 ]
Huang, Gang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nucl Med, Shanghai 200127, Peoples R China
[2] Shanghai Jiao Tong Univ, Inst Clin Nucl Med, Sch Med, Ren Ji Hosp, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200025, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China
[5] Shanghai Univ Med & Hlth Sci, Shanghai 201318, Peoples R China
基金
中国国家自然科学基金;
关键词
lung cancer; gefitinib; SREBP; chemotherapy; lipid metabolism; MEMBRANE-FLUIDITY; SMALL-MOLECULE; GROWTH; METABOLISM; ACTIVATION; EXPRESSION; RESISTANCE;
D O I
10.18632/oncotarget.10721
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The clinical success of EGFR inhibitors in patients with lung cancer is limited by the inevitable development of treatment resistance. Here, we show that inhibition of SREBP increase gefitinib sensitivity in vitro and in vivo. Interference of SREBP1 binding partner MARVELD1 potentiate the therapeutic effect of gefitinib as well. Mechanistically, SREBP inhibition decreases the cell membrane fluidity, results in a decreased tyrosine phosphorylation of EGFR. Therefore, targeting lipid metabolism combined with EGFR-TKIs is potentially a novel therapeutic strategies for cancer treatment.
引用
收藏
页码:52392 / 52403
页数:12
相关论文
共 23 条
[1]
Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs [J].
Adams, CM ;
Reitz, J ;
De Brabander, JK ;
Feramisco, JD ;
Li, L ;
Brown, MS ;
Goldstein, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) :52772-52780
[2]
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence [J].
Ettinger, SL ;
Sobel, R ;
Whitmore, TG ;
Akbari, M ;
Bradley, DR ;
Gleave, ME ;
Nelson, CC .
CANCER RESEARCH, 2004, 64 (06) :2212-2221
[3]
Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation [J].
Fiala, Ondrej ;
Pesek, Milos ;
Finek, Jindrich ;
Minarik, Marek ;
Benesova, Lucie ;
Bortlicek, Zbynek ;
Topolcan, Ondrej .
TUMOR BIOLOGY, 2015, 36 (08) :5801-5805
[4]
Effect of membrane fluidity on tyrosine kinase activity of reconstituted epidermal growth factor receptor [J].
Ge, GX ;
Wu, J ;
Lin, QS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) :511-514
[5]
Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[6]
SREBPs: metabolic integrators in physiology and metabolism [J].
Jeon, Tae-Il ;
Osborne, Timothy F. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2012, 23 (02) :65-72
[7]
A Small Molecule That Blocks Fat Synthesis By Inhibiting the Activation of SREBP [J].
Kamisuki, Shinji ;
Mao, Qian ;
Abu-Elheiga, Lutfi ;
Gu, Ziwei ;
Kugimiya, Akira ;
Kwon, Youngjoo ;
Shinohara, Tokuyuki ;
Kawazoe, Yoshinori ;
Sato, Shin-ichi ;
Asakura, Koko ;
Choo, Hea-Young Park ;
Sakai, Juro ;
Wakil, Salih J. ;
Uesugi, Motonari .
CHEMISTRY & BIOLOGY, 2009, 16 (08) :882-892
[8]
Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel [J].
Li, Jiajin ;
Zhao, Shiyan ;
Zhou, Xiang ;
Zhang, Teng ;
Zhao, Li ;
Miao, Ping ;
Song, Shaoli ;
Sun, Xiaoguang ;
Liu, Jianjun ;
Zhao, Xiaoping ;
Huang, Gang .
PLOS ONE, 2013, 8 (09)
[9]
Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis [J].
Li, Weihua ;
Tai, Yanhong ;
Zhou, Jie ;
Gu, Weiting ;
Bai, Zhaofang ;
Zhou, Tao ;
Zhong, Zhijiu ;
McCue, Peter A. ;
Sang, Nianli ;
Ji, Jun-Yuan ;
Kong, Beihua ;
Jiang, Jie ;
Wang, Chenguang .
CELL CYCLE, 2012, 11 (12) :2348-2358
[10]
Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth [J].
Liu, Liu ;
Zhao, Xiaoping ;
Zhao, Li ;
Li, Jiajin ;
Yang, Hao ;
Zhu, Zongping ;
Liu, Jianjun ;
Huang, Gang .
CANCER RESEARCH, 2016, 76 (05) :1260-1272